EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo

Jordan A Naumann, Prokopios P Argyris iD, Michael A Carpenter iD, Harshita B Gupta, Yanjun Chen, Nuri A Temiz, Yufan Zhou iD, Cameron Durfee iD, Joshua Proehl, Brenda L Koniar, Silvestro G Conticello iD, David A Largaespada iD und 4 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jordan A Naumann und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the APOBEC3 family of single-stranded DNA cytosine deaminases is well-known for its antiviral factors, these enzymes are rapidly gaining attention as prominent sources of mutation in cancer. APOBEC3′s signature single-base substitutions, C-to-T and C-to-G in TCA and TCT motifs, are evident in over 70% of human malignancies and dominate the mutational landscape of numerous individual tumors. Recent murine studies have established cause-and-effect relationships, with both human APOBEC3A and APOBEC3B proving capable of promoting tumor formation in vivo. Here, we investigate the molecular mechanism of APOBEC3A-driven tumor development using the murine Fah liver complementation and regeneration system. First, we show that APOBEC3A alone is capable of driving tumor development (without Tp53 knockdown as utilized in prior studies). Second, we show that the catalytic glutamic acid residue of APOBEC3A (E72) is required for tumor formation. Third, we show that an APOBEC3A separation-of-function mutant with compromised DNA deamination activity and wildtype RNA-editing activity is defective in promoting tumor formation. Collectively, these results demonstrate that APOBEC3A is a “master driver” that fuels tumor formation through a DNA deamination-dependent mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansAnimalsMiceDeaminationCytidine DeaminaseDNAMinor Histocompatibility AntigensProteins

Stichwörter der Autor:innen

APOBEC3ADNA deaminationDNA mutationRNA editingcarcinogenesishepatocellular carcinomamolecular mechanismtumorigenesis

Substanzen

Cytidine DeaminaseDNAMinor Histocompatibility AntigensAPOBEC3A protein, humanProteinsAPOBEC3B protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
  • Division of Oral and Maxillofacial Pathology, College of Dentistry, Ohio State University, Columbus, OH 43210, USA.
  • Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

ORCID-Profile: Prokopios P Argyris, Michael A Carpenter, Yufan Zhou, Cameron Durfee, Silvestro G Conticello, David A Largaespada, William L Brown, Hideki Aihara, Rachel I Vogel

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NCI
  • Cancer Prevention and Research Institute of Texas
  • CPRIT Research Training Award

Zitieren

APA

Naumann, J. A., Argyris, P. P., Carpenter, M. A., Gupta, H. B., Chen, Y., Temiz, N. A., Zhou, Y., Durfee, C., Proehl, J., Koniar, B. L., Conticello, S. G., Largaespada, D. A., Brown, W. L., Aihara, H., Vogel, R. I., & Harris, R. S. (2023). DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119305

Vancouver

Naumann JA, Argyris PP, Carpenter MA, Gupta HB, Chen Y, Temiz NA, et al. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119305

BibTeX
@article{Naumann2023,
  author = {Naumann, Jordan A and Argyris, Prokopios P and Carpenter, Michael A and Gupta, Harshita B and Chen, Yanjun and Temiz, Nuri A and Zhou, Yufan and Durfee, Cameron and Proehl, Joshua and Koniar, Brenda L and Conticello, Silvestro G and Largaespada, David A and Brown, William L and Aihara, Hideki and Vogel, Rachel I and Harris, Reuben S},
  title = {DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119305}
}
Kostenlos starten →